Chromatin remodeling at the Ig loci prior to V(D)J recombination

J Immunol. 2001 Jul 15;167(2):866-74. doi: 10.4049/jimmunol.167.2.866.

Abstract

Rearrangement of Ig H and L chain genes is highly regulated and takes place sequentially during B cell development. Several lines of evidence indicate that chromatin may modulate accessibility of the Ig loci for V(D)J recombination. In this study, we show that remodeling of V and J segment chromatin occurs before V(D)J recombination at the endogenous H and kappa L chain loci. In recombination-activating gene-deficient pro-B cells, there is a reorganization of nucleosomal structure over the H chain J(H) cluster and increased DNase I sensitivity of V(H) and J(H) segments. The pro-B/pre-B cell transition is marked by a decrease in the DNase I sensitivity of V(H) segments and a reciprocal increase in the nuclease sensitivity of Vkappa and Jkappa segments. In contrast, J(H) segments remain DNase I sensitive, and their nucleosomal organization is maintained in mu(+) recombination-activating gene-deficient pre-B cells. These results indicate that initiation of rearrangement is associated with changes in the chromatin structure of both V and J segments, whereas stopping recombination involves changes in only V segment chromatin. We further find an increase in histone H4 acetylation at both the H and kappa L chain loci at the pro-B cell stage. Although histone H4 acetylation appears to be an early change associated with B cell commitment, acetylation alone is not sufficient to promote subsequent modifications in Ig chromatin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • B-Lymphocytes / cytology
  • B-Lymphocytes / enzymology
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Cell Differentiation / genetics
  • Cell Differentiation / immunology
  • Cell Line, Transformed
  • Chromatin / drug effects
  • Chromatin / genetics*
  • Chromatin / metabolism*
  • Deoxyribonuclease I / metabolism
  • Gene Rearrangement, B-Lymphocyte, Heavy Chain* / drug effects
  • Gene Rearrangement, B-Lymphocyte, Light Chain* / drug effects
  • Genes, Immunoglobulin* / drug effects
  • Genetic Markers / immunology
  • Histones / metabolism
  • Hydroxamic Acids / pharmacology
  • Immunoglobulin Joining Region / genetics
  • Immunoglobulin Variable Region / genetics*
  • Immunoglobulin kappa-Chains / genetics
  • Lipopolysaccharides / pharmacology
  • Mice
  • Nucleosomes / genetics
  • Nucleosomes / metabolism
  • Recombination, Genetic / immunology
  • Stem Cells / metabolism
  • Tumor Cells, Cultured

Substances

  • Chromatin
  • Genetic Markers
  • Histones
  • Hydroxamic Acids
  • Immunoglobulin Joining Region
  • Immunoglobulin Variable Region
  • Immunoglobulin kappa-Chains
  • Lipopolysaccharides
  • Nucleosomes
  • trichostatin A
  • Deoxyribonuclease I